JP2014513983A5 - - Google Patents

Download PDF

Info

Publication number
JP2014513983A5
JP2014513983A5 JP2014510518A JP2014510518A JP2014513983A5 JP 2014513983 A5 JP2014513983 A5 JP 2014513983A5 JP 2014510518 A JP2014510518 A JP 2014510518A JP 2014510518 A JP2014510518 A JP 2014510518A JP 2014513983 A5 JP2014513983 A5 JP 2014513983A5
Authority
JP
Japan
Prior art keywords
cells
zscan4
seq
reprogramming
contacting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014510518A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014513983A (ja
JP6189829B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/037643 external-priority patent/WO2012158561A1/en
Publication of JP2014513983A publication Critical patent/JP2014513983A/ja
Publication of JP2014513983A5 publication Critical patent/JP2014513983A5/ja
Application granted granted Critical
Publication of JP6189829B2 publication Critical patent/JP6189829B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014510518A 2011-05-13 2012-05-11 Zscan4とzscan4依存性遺伝子を利用した体細胞の直接的な再プログラム化 Active JP6189829B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161486004P 2011-05-13 2011-05-13
US61/486,004 2011-05-13
US201161529055P 2011-08-30 2011-08-30
US61/529,055 2011-08-30
PCT/US2012/037643 WO2012158561A1 (en) 2011-05-13 2012-05-11 Use of zscan4 and zscan4-dependent genes for direct reprogramming of somatic cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017108578A Division JP2017212985A (ja) 2011-05-13 2017-05-31 Zscan4とzscan4依存性遺伝子を利用した体細胞の直接的な再プログラム化

Publications (3)

Publication Number Publication Date
JP2014513983A JP2014513983A (ja) 2014-06-19
JP2014513983A5 true JP2014513983A5 (enExample) 2015-07-16
JP6189829B2 JP6189829B2 (ja) 2017-08-30

Family

ID=47177285

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014510518A Active JP6189829B2 (ja) 2011-05-13 2012-05-11 Zscan4とzscan4依存性遺伝子を利用した体細胞の直接的な再プログラム化
JP2017108578A Pending JP2017212985A (ja) 2011-05-13 2017-05-31 Zscan4とzscan4依存性遺伝子を利用した体細胞の直接的な再プログラム化

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017108578A Pending JP2017212985A (ja) 2011-05-13 2017-05-31 Zscan4とzscan4依存性遺伝子を利用した体細胞の直接的な再プログラム化

Country Status (6)

Country Link
US (1) US9932560B2 (enExample)
EP (1) EP2707479B1 (enExample)
JP (2) JP6189829B2 (enExample)
AU (1) AU2012256014B2 (enExample)
CA (1) CA2835825C (enExample)
WO (1) WO2012158561A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6189829B2 (ja) 2011-05-13 2017-08-30 ザ・ユナイテッド・ステイツ・オブ・アメリカ・アズ・リプリゼンティド・バイ・ザ・セクレタリー・フォー・ザ・デパートメント・オブ・ヘルス・アンド・ヒューマン・サービシズ Zscan4とzscan4依存性遺伝子を利用した体細胞の直接的な再プログラム化
CA3176825A1 (en) 2013-03-15 2014-09-18 Elixirgen Therapeutics, Inc. Methods of using zscan4 for treating a disease or condition associated with a karyotype abnormality
WO2016099602A1 (en) * 2014-12-18 2016-06-23 University Of Utah Research Foundation Induced pluripotent stem cell and method for producing the same
CN105219729B (zh) * 2015-09-28 2018-09-25 首都医科大学宣武医院 一种利用非整合质粒载体诱导神经干细胞的方法及其用途
CN106800590B (zh) * 2015-11-25 2021-04-09 杭州智鹤丹谷生物医药有限公司 一种结合多种淀粉样蛋白单体和聚集体的多肽及其应用
CN110268072B (zh) * 2016-12-15 2023-11-07 Illumina公司 确定旁系同源基因的方法和系统
CN107475378B (zh) * 2017-08-03 2021-03-30 复旦大学 用于检测女性原发不孕的patl2基因及检测该基因突变的试剂盒
WO2019060450A1 (en) * 2017-09-19 2019-03-28 The Broad Institute, Inc. METHODS AND SYSTEMS FOR RECONSTRUCTION OF DEVELOPMENT LANDSCAPES BY OPTIMAL TRANSPORT ANALYSIS
CN107988147B (zh) * 2017-12-19 2021-11-09 江汉大学 基于器官芯片与诱导多能干细胞的定向分化用于3d拟表皮构建的方法
US20220306730A1 (en) * 2019-05-22 2022-09-29 University Of Maryland, Baltimore Methods of treating cancer by targeting zscan4 activity in cancer stem cells
CN110616232B (zh) * 2019-09-23 2023-04-11 中国人民解放军陆军军医大学 Sox30敲除和可恢复型小鼠动物模型构建方法及应用
CN121045395A (zh) * 2019-11-22 2025-12-02 阿尔卡梅纳干细胞治疗有限公司 用于去抑制re1沉默转录因子靶基因的组合物和方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980289A (en) 1987-04-27 1990-12-25 Wisconsin Alumni Research Foundation Promoter deficient retroviral vector
US5888762A (en) 1990-06-05 1999-03-30 Centre National De La Recherche Scientifique (Cnrs) Neurotropic growth factors comprising a homeobox peptide
KR100201352B1 (ko) 1995-03-16 1999-06-15 성재갑 단일주사 백신 제형
US7198784B2 (en) 1996-10-17 2007-04-03 Oxford Biomedica (Uk) Limited Retroviral vectors
FR2762615B1 (fr) 1997-04-28 1999-07-16 Inst Nat Sante Rech Med Nouveau site interne d'entree des ribosomes et vecteur le contenant
CA2375880A1 (en) 1999-06-22 2000-12-28 Dnavec Research Inc. A vector for the expression of two foreign genes
US20110171185A1 (en) * 1999-06-30 2011-07-14 Klimanskaya Irina V Genetically intact induced pluripotent cells or transdifferentiated cells and methods for the production thereof
DE19933492B4 (de) 1999-07-16 2008-01-10 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Konjugat zur Vermittlung eines zell-, kompartiment- oder membranspezifischen Transports von Wirksubstanzen, Verfahren zu dessen Herstellung und dessen Verwendung
JP2003514564A (ja) 1999-11-24 2003-04-22 エムシーエス マイクロ キャリア システムズ ゲーエムベーハー 核局在化シグナルまたはタンパク質導入領域の多量体を含むポリペプチド、および分子を細胞内へ移入するためのその使用法
US7211247B2 (en) 2001-04-09 2007-05-01 University Of Southern California Lentivirus vectors for gene transfer to alveolar epithelial cells
US7081489B2 (en) 2001-08-09 2006-07-25 Florida State University Research Foundation Polymeric encapsulation of nanoparticles
US20040014209A1 (en) 2002-01-23 2004-01-22 Lassar Andrew B. Compositions and methods for modulating cell differentiation
US7354763B2 (en) 2002-04-16 2008-04-08 Technion Research & Development Foundation Ltd. Generating vascular smooth muscle cells in vitro from ES cells
CA2495478A1 (en) 2002-08-05 2004-02-12 University Of Rochester Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
KR100591936B1 (ko) 2002-11-12 2006-06-22 포휴먼텍(주) 세포내 dna/rna 전달 방법, 및 이것의 기초 및임상학적 응용
CA2516116A1 (en) 2003-01-16 2004-08-05 St. John's University Nanoparticle based stabilization of ir fluorescent dyes
US7166692B2 (en) 2003-03-04 2007-01-23 Canbrex Bio Science Walkersville, Inc. Intracellular delivery of small molecules, proteins, and nucleic acids
US7682828B2 (en) 2003-11-26 2010-03-23 Whitehead Institute For Biomedical Research Methods for reprogramming somatic cells
SG188122A1 (en) 2004-01-23 2013-03-28 Advanced Cell Tech Inc Improved modalities for the treatment of degenerative diseases of the retina
WO2006052285A2 (en) 2004-05-13 2006-05-18 The Trustees Of Columbia University In The City Of New York Polymeric nanoparticles and nanogels for extraction and release of compounds
US20060024331A1 (en) 2004-08-02 2006-02-02 Ester Fernandez-Salas Toxin compounds with enhanced membrane translocation characteristics
JP2008528038A (ja) 2005-01-31 2008-07-31 エス セル インターナショナル ピーティーイー リミテッド 胚性幹細胞の指示された分化及びその利用
DE602006000381T2 (de) 2005-04-28 2008-12-18 Nipro Corp., Osaka Bioabsorbierbare pharmazeutische Zusammensetzung enthaltend einen PLGA-Copolymer
CA2605551A1 (en) 2005-05-10 2006-11-16 Naomi Balaban Compositions for administering rnaiii-inhibiting peptides
US8278104B2 (en) 2005-12-13 2012-10-02 Kyoto University Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
KR101420740B1 (ko) 2005-12-13 2014-07-17 교또 다이가꾸 핵초기화 인자
US20090227032A1 (en) 2005-12-13 2009-09-10 Kyoto University Nuclear reprogramming factor and induced pluripotent stem cells
EP2129771B1 (en) 2007-03-26 2018-09-12 The Government of the U.S.A. as represented by the Secretary of the Department of Health & Human Services Methods for modulating embryonic stem cell differentiation
ES2722198T3 (es) 2008-05-02 2019-08-08 Univ Kyoto Método de reprogramación nuclear
EP2473598B1 (en) * 2009-09-04 2017-03-22 The U.S.A. As Represented By The Secretary, Department Of Health And Human Services Methods for enhancing genome stability and telomere elongation in embryonic stem cells
WO2012129342A1 (en) 2011-03-23 2012-09-27 Ko Minoru S H Compositions and methods for enhancing the pluripotency of stem cells
JP6189829B2 (ja) 2011-05-13 2017-08-30 ザ・ユナイテッド・ステイツ・オブ・アメリカ・アズ・リプリゼンティド・バイ・ザ・セクレタリー・フォー・ザ・デパートメント・オブ・ヘルス・アンド・ヒューマン・サービシズ Zscan4とzscan4依存性遺伝子を利用した体細胞の直接的な再プログラム化

Similar Documents

Publication Publication Date Title
JP2014513983A5 (enExample)
Ratajczak et al. A novel view of the adult stem cell compartment from the perspective of a quiescent population of very small embryonic-like stem cells
Roubelakis et al. Amniotic fluid and amniotic membrane stem cells: marker discovery
EP2826855B1 (en) Myocardial sheet
KR101686722B1 (ko) 신경줄기세포 제조를 위한 배지와 그의 용도
CN102844428B (zh) Ets2和mesp1由成纤维细胞生成心脏祖细胞
Lee et al. iPSC-derived MSCs are a distinct entity of MSCs with higher therapeutic potential than their donor-matched parental MSCs
US20150232810A1 (en) Methods of preparing pluripotent stem cells
Abu Kasim et al. Unique molecular signatures influencing the biological function and fate of post‐natal stem cells isolated from different sources
Hong et al. Ontogeny of human umbilical cord perivascular cells: molecular and fate potential changes during gestation
JP6373253B2 (ja) 新規心筋細胞マーカー
JP6025067B2 (ja) 新規心筋細胞マーカー
JP2011068660A5 (enExample)
Zhao et al. Heparan Sulfate Chain‐Conjugated Laminin‐E8 Fragments Advance Paraxial Mesodermal Differentiation Followed by High Myogenic Induction from hiPSCs
Gao et al. A plethora of human pluripotent stem cells
JP2012532592A5 (enExample)
AU2018286654A1 (en) Cell reprogramming to cardiomyocytes
CN102628029B (zh) 地贫诱导多能干细胞及其制备方法和用途
JPWO2016114341A1 (ja) 多能性細胞識別化合物
KR20230113768A (ko) 유도 줄기 세포
Paulitschek et al. Generation and characterization of two iPSC lines from human epicardium-derived cells
CN104450622A (zh) 一种重组细胞系、其制备方法和应用
Derish et al. Multifaceted role of induced pluripotent stem cells in preclinical cardiac regeneration research
CN115175986B (zh) 用于诱导多能干细胞向脑毛细血管内皮样细胞分化的涂布剂及其利用
Guo et al. Cocktail of chemical compounds and recombinant proteins robustly promote the stemness of adipose-derived stem cells